Evidence map›Paper›PMID 41370205›Full record

ArticleBlood advances2026

Neutrophil cathepsin G potentiates biased signaling through protease-activated receptor 4.

NaShea C Kendrick, Germaine J Harvey, Sofia A Castro, Carson J Rohan, Xu Han, Marvin T Nieman

Abstract read
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

NaShea C KendrickDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.ORCID 0000-0003-3661-5309
Germaine J HarveyDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.ORCID 0000-0002-6208-4268
Sofia A CastroDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.ORCID 0009-0002-5353-8114
Carson J RohanDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.ORCID 0009-0002-8147-6336
Xu HanDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.ORCID 0000-0002-1977-1046
Marvin T NiemanDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH.ORCID 0000-0003-2602-023X

Funding

The role of protease activated receptors on platelets.R01HL098217 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI NIEMAN, MARVIN THOMAS · 2010 to 2024
$4.6M
NHLBI NIH HHS R01 HL098217
6 · The paper itself

Abstract

abstractPlatelets and neutrophils play a complex role in inflammation and thrombosis. Platelets are crucial for hemostasis, forming platelet plugs at the site of vascular injury. They are also drivers of venous thromboembolism, and they participate in immune responses by interacting with neutrophils. Neutrophil recruitment to platelet plugs is integral to resolve vascular injury, but excessive neutrophil infiltration can shift the response from hemostatic to thrombotic. The neutrophil protease cathepsin G (CatG) cleaves protease-activated receptor 4 (PAR4) at alternative sites to those cleaved by thrombin, but the signaling and physiological outcomes of this interaction are understudied. Considering the interaction between platelets and neutrophils, CatG may provide a mechanism for context-specific signaling through PAR4. We used light transmission aggregometry and flow cytometry to measure platelet aggregation, integrin activation, and P-selectin surface expression on human platelets in response to CatG or the RALLLGWVPTR (RALL 11-mer), which mimics PAR4 cleavage by CatG at Ser67. We observed calcium mobilization, RhoA activation, and protein kinase B (Akt) phosphorylation in platelets to investigate which PAR4 signaling pathways are activated by CatG. Here, we show that CatG cleaves PAR4 expressed on the surface of cells at a different site than thrombin. Both CatG and the RALL 11-mer increase platelet aggregation, integrin activation, and P-selectin surface expression. Additionally, CatG activation of PAR4 increases calcium mobilization and Akt phosphorylation in platelets. The RALL 11-mer increases Akt phosphorylation to activate platelets. These results indicate that CatG uses Gαq and β-arrestin pathways to facilitate platelet aggregation in the absence of Gα12/13 signaling.

Indexed as

Cathepsin GNeutrophilsReceptors, ThrombinSignal TransductionBlood PlateletsHumansPlatelet AggregationCathepsin GCTSG protein, humanprotease-activated receptor 4Receptors, Thrombin

Identifiers

PMID41370205
PMCPMC12927046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.